BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 9712084)

  • 1. CC chemokine receptor 5 polymorphism in rheumatoid arthritis.
    Garred P; Madsen HO; Petersen J; Marquart H; Hansen TM; Freiesleben Sørensen S; Volck B; Svejgaard A; Andersen V
    J Rheumatol; 1998 Aug; 25(8):1462-5. PubMed ID: 9712084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCR5 (chemokine receptor-5) DNA-polymorphism influences the severity of rheumatoid arthritis.
    Zapico I; Coto E; Rodríguez A; Alvarez C; Torre JC; Alvarez V
    Genes Immun; 2000; 1(4):288-9. PubMed ID: 11196706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of rheumatoid arthritis with a functional chemokine receptor, CCR5.
    Gómez-Reino JJ; Pablos JL; Carreira PE; Santiago B; Serrano L; Vicario JL; Balsa A; Figueroa M; de Juan MD
    Arthritis Rheum; 1999 May; 42(5):989-92. PubMed ID: 10323455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCR5-Delta32 genetic polymorphism associated with benign clinical course and magnetic resonance imaging findings in Brazilian patients with multiple sclerosis.
    Kaimen-Maciel DR; Reiche EM; Brum Souza DG; Frota Comini ER; Bobroff F; Morimoto HK; Ehara Watanabe MA; Carvalho De Oliveira J; Matsuo T; Lopes J; Donadi EA
    Int J Mol Med; 2007 Sep; 20(3):337-44. PubMed ID: 17671738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of CCR5-Delta32 deletion in human immunodeficiency virus type 1 (HIV-1) in healthy blood donors, HIV-1-exposed seronegative and HIV-1-seropositive individuals of southern Brazilian population.
    Reiche EM; Ehara Watanabe MA; Bonametti AM; Morimoto HK; Akira Morimoto A; Wiechmann SL; Matsuo T; Carvalho De Oliveira J; Vissoci Reiche F
    Int J Mol Med; 2008 Nov; 22(5):669-75. PubMed ID: 18949389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential CCR5Delta32 allelic frequencies in juvenile idiopathic arthritis subtypes: evidence for different regulatory roles of CCR5 in rheumatological diseases.
    Scheibel I; Veit T; Neves AG; Souza L; Prezzi S; Machado S; Kohem C; Icarelli M; Xavier R; Brenol JC; Chies JA
    Scand J Rheumatol; 2008; 37(1):13-7. PubMed ID: 18189189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the CCR5 Delta32 polymorphism in abdominal aortic aneurysms.
    Sandford B; Bown M; London N; Sayers R
    Int J Immunogenet; 2009 Aug; 36(4):199-205. PubMed ID: 19476483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population.
    Apostolakis S; Baritaki S; Krambovitis E; Spandidos DA
    J Clin Virol; 2005 Dec; 34(4):310-4. PubMed ID: 16286055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].
    Wasik TJ; Smoleń J; Kruszyński P; Bratosiewicz-Wasik J; Beniowski M
    Wiad Lek; 2005; 58(9-10):500-7. PubMed ID: 16529059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of highly active antiretroviral therapy failure with chemokine receptor 5 wild type.
    Bogner JR; Lutz B; Klein HG; Pollerer C; Troendle U; Goebel FD
    HIV Med; 2004 Jul; 5(4):264-72. PubMed ID: 15236615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for negative association of the chemokine receptor CCR5 d32 polymorphism with rheumatoid arthritis.
    Pokorny V; McQueen F; Yeoman S; Merriman M; Merriman A; Harrison A; Highton J; McLean L
    Ann Rheum Dis; 2005 Mar; 64(3):487-90. PubMed ID: 15331395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of the mutated delta 32 allele of the CCR5 gene in a Sicilian population.
    Sidoti A; D'Angelo R; Rinaldi C; De Luca G; Pino F; Salpietro C; Giunta DE; Saltalamacchia F; Amato A
    Int J Immunogenet; 2005 Jun; 32(3):193-8. PubMed ID: 15932625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of association between the chemokine receptor 5 polymorphism CCR5delta32 in rheumatoid arthritis and juvenile idiopathic arthritis.
    Lindner E; Nordang GB; Melum E; Flatø B; Selvaag AM; Thorsby E; Kvien TK; Førre OT; Lie BA
    BMC Med Genet; 2007 Jun; 8():33. PubMed ID: 17565662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The chemokine receptor CCR5 genetic polymorphism and expression in rheumatoid arthritis patients.
    Kohem CL; Brenol JC; Xavier RM; Bredemeier M; Brenol CV; Dedavid e Silva TL; de Castilhos Mello A; Cañedo AD; Neves AG; Chies JA
    Scand J Rheumatol; 2007; 36(5):359-64. PubMed ID: 17963165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the CC chemokine receptor 5 delta32 polymorphism in a Brazilian population with cutaneous leishmaniasis.
    Brajão de Oliveira K; Reiche EM; Kaminami Morimoto H; Pelegrinelli Fungaro MH; Estevão D; Pontello R; Franco Nasser T; Watanabe MA
    J Cutan Pathol; 2007 Jan; 34(1):27-32. PubMed ID: 17214851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chemokine receptor CCR5-Delta32 gene mutation is not protective against Alzheimer's disease.
    Combarros O; Infante J; Llorca J; Peña N; Fernández-Viadero C; Berciano J
    Neurosci Lett; 2004 Aug; 366(3):312-4. PubMed ID: 15288441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variations in CC chemokine receptors and hypertension.
    Zhang M; Ardlie K; Wacholder S; Welch R; Chanock S; O'Brien TR
    Am J Hypertens; 2006 Jan; 19(1):67-72. PubMed ID: 16461193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of association of C-C chemokine receptor 5 Δ32 deletion status with rheumatoid arthritis, systemic lupus erythematosus, lupus nephritis, and disease severity.
    Martens HA; Gross S; van der Steege G; Brouwer E; Berden JH; de Sevaux R; Derksen RH; Voskuyl AE; Berger SP; Navis GJ; Kallenberg CG; Bijl M
    J Rheumatol; 2010 Nov; 37(11):2226-31. PubMed ID: 20682662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of the HIV resistance CCR5-Delta32 allele among Egyptians and Syrians.
    Salem AH; Batzer MA
    Mutat Res; 2007 Mar; 616(1-2):175-80. PubMed ID: 17166523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.
    Promrat K; McDermott DH; Gonzalez CM; Kleiner DE; Koziol DE; Lessie M; Merrell M; Soza A; Heller T; Ghany M; Park Y; Alter HJ; Hoofnagle JH; Murphy PM; Liang TJ
    Gastroenterology; 2003 Feb; 124(2):352-60. PubMed ID: 12557141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.